Hypothesis

Exposure to ultraviolet B (UVB) radiation from sunlight stimulates the synthesis of vitamin D in the skin, which plays a critical role in calcium metabolism, immune function, and overall health.

Key Findings

Sunlight exposure stimulates vitamin D synthesis in skin through UVB radiation converting 7-dehydrocholesterol to vitamin D3. This process supports calcium homeostasis, bone health, and immune function. Optimal moderate exposure can maintain adequate vitamin D status while balancing skin cancer risks.

Proposed Mechanisms

• UVB conversion: UVB radiation converts 7-dehydrocholesterol in the skin into vitamin D3 • Metabolic processing: Vitamin D3 is metabolized in the liver and kidneys into active forms • Physiological regulation: Active vitamin D regulates calcium and phosphorus balance • Immune modulation: Supports immune system modulation and cellular health

Research Implications

Hypothesis

If X-linked OGT dosage determines sex differences in longevity through hexosamine biosynthetic pathway (HBP) flux and O‑GlcNAc‑mediated proteostasis, then equalizing OGT expression between sexes will eliminate the female survival advantage under isoglycemic conditions.

Mechanistic Rationale

OGT is encoded on the X chromosome and escapes inactivation in a subset of tissues, potentially giving females higher O‑GlcNAc transferase activity【https://pmc.ncbi.nlm.nih.gov/articles/PMC3985334/】. Elevated O‑GlcNAcylation modifies key regulators of the heat‑shock response (HSF1) and autophagy (TFEB), enhancing chaperone expression and autophagic flux, which reduces protein aggregate burden【https://www.pnas.org/doi/10.1073/pnas.1205748109】. Concurrently, HBP flux rises with normal aging【https://doi.org/10.1101/2023.11.17.567640】 and drives pathological O‑GlcNAcylation when unbalanced, but a moderate increase supports proteostasis【https://www.ahajournals.org/doi/10.1161/JAHA.119.014046】. Because GFAT is the rate‑limiting step【https://pmc.ncbi.nlm.nih.gov/articles/PMC1343508/】, females may maintain a more favorable O‑GlcNAc cycling set‑point that buffers against aggregate‑induced toxicity.

Experimental Design

1. Model: Use C57BL/6J mice with a floxed Ogt allele and a Cre‑ERt2 system for inducible, tissue‑specific knockdown or overexpression.
2. Groups (n=30 per sex per group):
   • Females with Ogt knockdown to ~50 % (male‑like) expression.
   • Males with Ogt overexpression to ~150 % (female‑like) expression.
   • Sex‑matched controls receiving vehicle.

Hypothesis

The age‑associated increase in AP‑1 binding to cis‑regulatory elements is driven by an age‑upregulated long non‑coding RNA, AGING‑R, which acts as a molecular scaffold that recruits AP‑1 (and its co‑activator p300) to aging‑associated enhancers while simultaneously sequestering AP‑1 away from youth‑associated promoters.

Mechanistic rationale

• AP‑1 functions as a master upstream controller of aging hallmarks by remodeling chromatin accessibility, converting youth‑associated regions into a closed state and opening aging‑associated regions {[longevity.technology/news/master-controller-of-aging-and-development-uncovered/]}
• This remodeling follows a predictable trajectory from development through senescence, reflecting progressive AP‑1 binding to cCREs {[imb.uq.edu.au/article/2024/06/revealing-master-controller-development-and-ageing]}
• Parallel epigenetic controllers such as the MLL complex and BMAL1‑mTORC1 axis demonstrate that transcriptional complexes can be tethered to specific genomic loci by non‑coding RNAs {[pubmed.ncbi.nlm.nih.gov/38177329/]} {[www.aging-us.com/article/100633/text]}
• Numerous lncRNAs (e.g., HOTAIR, MALAT1) serve as scaffolds that bring transcription factors and chromatin modifiers to target sites, providing a proven mechanism for RNA‑dependent targeting {[doi.org/10.1016/j.cell.2018.02.005]}
• We propose that AGING‑R expression is low in youth, rises with age due to mTORC1‑dependent transcription (consistent with BMAL1 loss‑of‑function leading to elevated mTOR activity), and that AGING‑R contains multiple AP‑1‑binding motifs

Hypothesis

A coordinated decline across the hallmarks of aging is driven by loss of colonic butyrate‑producing bacteria, which removes a key microbial metabolite that simultaneously regulates epigenetic, metabolic, and immune pathways in the host.

Mechanistic rationale

Butyrate functions as a histone deacetylase inhibitor (HDACi) and a ligand for GPR109A on colonocytes and immune cells. Through HDAC inhibition, butyrate increases acetylation of FOXO3 and PGC‑1α promoters, enhancing stress‑resistance transcription and mitochondrial biogenesis. Simultaneously, GPR109A activation triggers β‑arrestin–biased signaling that suppresses NF‑κB–mediated inflammaging and promotes autophagy via AMPK activation. When butyrate‑producing taxa such as Faecalibacterium prausnitzii and Eubacterium rectale decline with age, these protective signals wane, leading to:

• Epigenetic drift – reduced histone acetylation at longevity loci
• Mitochondrial dysfunction – lowered PGC‑1α activity and oxidative phosphorylation
• Cellular senescence – increased p16^INK4a^ due to loss of FOXO3‑mediated cell‑cycle control
• Stem cell exhaustion – impaired colonocyte renewal from diminished HDACi‑dependent Wnt modulation
• Inflammaging – unchecked NF‑κB activity and cytokine production Thus, the microbiota‑butyrate axis acts as an upstream controller whose loss produces the correlated suite of aging phenotypes.

Testable predictions

1. Cross‑sectional correlation – Older adults with higher fecal butyrate concentrations will show younger epigenetic clocks (e.g., lower GrimA

Hypothesis

The X‑linked epigenetic regulator KDM6A, expressed at higher dosage in XX cells, cell‑autonomously augments colonic expression of the butyrate transporter SLC5A8 and the mucin gene MUC2. This drives increased luminal butyrate uptake, enhances colonocyte ATP production, and shapes a microbiome enriched in butyrate‑producers, thereby providing a mechanistic basis for the female advantage in gut‑mediated longevity.

Mechanistic Model

KDM6A demethylates H3K27me3 at promoters of metabolic and barrier genes. In intestinal epithelial cells, higher KDM6A activity in XX individuals sustains an open chromatin state at Slc5a8 and Muc2, elevating their transcription. Greater SLC5A8 boosts butyrate import, which fuels mitochondrial oxidation and supplies ~70‑80% of colonocyte energy needs【https://pmc.ncbi.nlm.nih.gov/articles/PMC8002420/】. Elevated MUC2 thickens the mucus layer, favoring colonization by mucin‑utilizing, butyrate‑producing taxa such as Bifidobacterium spp., a pattern observed in the world’s oldest woman【https://microbiomepost.com/gut-microbiota-linked-to-healthy-longevity-in-the-worlds-oldest-woman/】. The resulting rise in circulating butyrate reduces systemic inflammation via GPR109A signaling on macrophages, reinforcing the stronger innate immunity seen in female centenarians【https://www.fightaging.org/archives/2025/03/differences-in-the-gut-microbiome-and-immune-function-in-male-versus-female-centenarians/】. Conversely, XY cells with a single KDM6A copy exhibit lower Slc5a8/Muc2 expression, diminished butyrate uptake, a less beneficial mic

Hypothesis

Butyrate produced by colonic Firmicutes acts as a metabolic rheostat that programs the order in which autophagy substrates are engaged during nutrient stress. When butyrate is abundant, colonocytes preferentially activate mitophagy, followed by lipophagy and finally aggrephagy, preserving mitochondrial function while recycling lipids and protein aggregates. Declining butyrate with age reverses or flattens this hierarchy, causing premature engagement of bulk autophagy or aggrephagy before damaged mitochondria are cleared, leading to mitochondrial ROS accumulation, epithelial barrier loss, and inflammaging.

Mechanistic Rationale

Butyrate inhibits HDACs and activates GPR109A, resulting in reduced mTORC1 signaling and increased AMPK activity. These shifts promote phosphorylation of ULK1 and activation of the autophagy initiation complex. Importantly, butyrate‑dependent acetylation of specific autophagy receptors (e.g., NIX for mitophagy, LC3‑interacting region of p62 for aggrephagy) alters their affinity for cargo. We propose that high butyrate sustains NIX deacetylation, enhancing its binding to depolarized mitochondria, while low butyrate leads to hyperacetylated NIX with reduced mitochondrial affinity, shifting receptor preference toward p62‑mediated protein aggregate capture.

Testable Predictions

1. In vitro – Treat polarized human colonocyte monolayers with physiological butyrate (1‑5 mM) versus vehicle, then induce mild nutrient deprivation (EBSS). Measure flux through mitophagy (mt‑Keima), lipophagy (BODIPY‑C12), and aggrephagy (GFP‑LC3‑p62 r

Hypothesis

Ultra‑cold (≥34 °F/1.1 °C) exposures of ≤3 min activate a sympathetic‑driven metabolic shift that, when shivering occurs, produces the same downstream signals—PGC‑1α upregulation, increased UCP1 expression, and enhanced autophagy—as 10‑15 min immersions at 5‑10 °C, thereby compressing the time required for chronic cold‑adaptation.

Mechanistic rationale

• The initial cold shock provokes a rapid surge in norepinephrine and dopamine, activating β‑adrenergic receptors on brown adipocytes and skeletal muscle.
• Norepinephrine‑stimulated cAMP production triggers PKA‑dependent phosphorylation of hormone‑sensitive lipase, liberating fatty acids that uncouple mitochondrial respiration via UCP1.
• If the exposure is intense enough to elicit vigorous shivering, ATP consumption rises sharply, raising the AMP/ATP ratio and activating AMPK.
• AMPK directly phosphorylates and activates PGC‑1α, promoting mitochondrial biogenesis, and also initiates ULK1‑dependent autophagy, mirroring the effects seen after longer, milder cold exposures.
• Consequently, the sympathetic‑metabolic cascade (β‑adrenergic → PKA → AMPK → PGC‑1α/UCP1/autophagy) can be reached in a shorter time frame when temperature extremity compensates for duration.

Testable predictions

1. Hormone levels: Plasma norepinephrine and dopamine will peak within 2 min of a 34 °F, 3‑min immersion and return to baseline by 10 min, matching the profile reported after longer 5‑10 °C exposures.
2. Shivering threshold: Participants who exhibit ≥15 % of maximal voluntary shivering (measured via electromyograp

Hypothesis

In aged regenerating tissue, the Hedgehog (Hh) pathway deficit arises not from SMO dysfunction but from an age‑induced increase in HDAC3 activity that selectively removes H3K27 acetylation at GLI3‑bound repressor enhancers. This creates a chromatin environment that favors GLI3 repressor occupancy and suppresses GLI1 activator function, thereby biasing the GLI gradient toward repression. Supraphysiological SMO stimulation (e.g., high‑dose SAG) can overcome this blockade by two coupled mechanisms: (1) heightened GLI1 phosphorylation that reduces its affinity for HDAC complexes, and (2) enhanced adenosine‑to‑inosine (A‑to‑I) RNA editing of GLI1 transcripts, which increases GLI1 transcriptional potency and competitively displaces GLI3 from shared DNA sites.

Mechanistic Rationale

• Epigenetic gatekeeper: HDAC3 is known to deacetylate H3K27 at enhancers, converting active chromatin to a repressed state. Aging elevates HDAC3 expression in fibroblasts and satellite cells (see HDAC activity shifts in aged muscle)【https://pmc.ncbi.nlm.nih.gov/articles/PMC10111369/】. We propose that HDAC3 is recruited to GLI3‑bound HH‑dependent enhancers via a protein‑protein interface that strengthens with age, leading to focal loss of H3K27ac specifically at these sites.
• GLI gradient shift: GLI3 repressor competes with GLI1 activator for overlapping binding motifs. Loss of H3K27ac diminishes GLI1 binding affinity while preserving or increasing GLI3 binding (GLI3 prefers hypoacetylated chromatin). Consequently, the ratio of GLI1‑to‑GLI3 occupancy at HH‑responsive loci drop

Hypothesis

Aging of the vocal fold lamina propria results not merely from passive accumulation of collagen and loss of elastin, but from a failure of phonation‑induced mechanotransduction to maintain fibroblast homeostasis. In young tissue, cyclic tensile strain during phonation activates integrin‑FAK‑YAP/TAZ signaling in fibroblasts, promoting a contractile, matrix‑remodeling phenotype that balances collagen I/III deposition with elastin synthesis and regulates collagen‑fibrillogenesis proteins (lumican, fibromodulin, decorin) [Collagen regulatory proteins shift during aging]. With age, reduced vibratory amplitude and altered strain patterns diminish this mechanochemical drive, leading to fibroblast senescence or a maladaptive myofibroblast shift that overproduces stiff collagen while suppressing elastin [Collagen accumulation and elastin loss characterize aged vocal folds]. This hypothesis predicts that restoring physiologic strain patterns—either via targeted phonatory exercise or functional electrical stimulation (FES) that induces muscle hypertrophy and restores mucosal wave dynamics [FES produces substantial muscle hypertrophy]—will reactivate YAP/TAZ signaling, normalize collagen regulatory protein expression, and reverse ECM stiffness.

Testable Predictions

1. In vitro strain response: Primary vocal fold fibroblasts isolated from y

We hypothesize that mTORC1 activity in symbiont‑bearing host cells oscillates on a roughly 24‑hour rhythm, and that these pulses synchronize host cell proliferation with symbiont division to optimize photosynthate exchange and maintain holobiont homeostasis. In the civilizational state (high mTOR), host cells drive anabolic processes—ribosome biogenesis, lipid synthesis, and extracellular vesicle (EV) release—that expand the symbiosome membrane and provision nutrients to zooxanthellae. In the survival state (low mTOR), autophagy is activated to recycle damaged proteins and lipids, limiting oxidative stress and preventing EV overload. The alternation creates a metabolic window where growth phases build symbiotic capacity while clearance phases remove stress‑induced damage, a balance that chronic mTOR suppression or activation disrupts.

This dynamic coupling extends the civilization‑versus‑survival dial concept by adding a temporal dimension: the holobiont does not simply switch between modes but cycles through them, much like a cellular circadian clock. We propose that the mTOR pulse is entrained by the light‑dark cycle and reinforced by redox‑sensitive AMPK signaling, which rises during the night phase to transiently inhibit mTORC1 and trigger autophagic flux. When this rhythm is intact, susceptible species such as Orbicella faveolata can still mount a protective autophagy burst during infection, whereas disease‑tolerant Porites spp. exhibit higher amplitude oscillations that allow rapid return to growth after stress.

Testable predictions

1. Oscillation detection

Hypothesis

Restoring a youthful gut microbiome composition that produces rhythmic, pulsatile butyrate release—combined with targeted vagal nerve stimulation—will reverse senescence in aged cardiac c-Kit+ progenitor cells (CPCs) by stabilizing HIF‑1α, enhancing autophagic flux, and suppressing the SASP, thereby rescuing their proliferative and paracrine capacity.

Rationale

• Aged CPCs exhibit high p16^INK4a^ and SA‑β‑gal positivity, reduced proliferation, and deficient secretion of reparative factors {pubmed.ncbi.nlm.nih.gov/28737214/}.
• Butyrate, a microbiota‑derived short‑chain fatty acid, activates GPR41/43, inhibits HDACs, and promotes IL‑10‑producing Tregs, which dampen cardiac inflammation {frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2025.1572948/full}.
• Vagal tone correlates with microbiota diversity and inversely with systemic IL‑6 and CRP {pubmed.ncbi.nlm.nih.gov/36246995/}; acetylcholine released from vagal terminals engages α7nAChR on macrophages to curb NF‑κB signaling {tandfonline.com/doi/full/10.1080/19490976.2023.2290331}.
• HDAC inhibition by butyrate can stabilize HIF‑1α under normoxia, driving transcription of BNIP3 and LC3, which promote mitophagy and autophagy—a pathway already shown to improve aged CPC function when PI3K‑Akt is inhibited {[pmc.ncbi.nlm.nih.gov/ar

Hypothesis: The liver’s attempt to remove inefficient hepatocytes via ferroptosis is subverted by Nrf2‑driven metabolic reprogramming that creates a survival‑competent but senescent population. These ferroptosis‑adapted hepatocytes upregulate cystine/glutamate exchange (SLC7A11) to boost glutathione, thereby resisting lipid‑peroxide‑dependent death【Aging promotes ferroptotic signaling in hepatocytes, creating ferroptosis-adapted cells that survive but remain dysfunctional](https://pmc.ncbi.nlm.nih.gov/articles/PMC12810195/)】. The heightened cystine uptake depletes extracellular cystine, compromising the antioxidant capacity of neighboring Zone 2 hepatocytes and distorting the oxidative gradient that patterns Wnt/β‑catenin signaling. Senescent adapted cells further secrete Wnt antagonists such as DKK1 and sFRPs, flattening the zonation cascade. Consequently, metabolic zonation collapses, lipogenic enzymes invade periportal zones, and fatty acid oxidation fails in pericentral regions, driving steatosis. This mechanism is especially pronounced in Zone 3, where low oxygen predisposes cells to ferroptotic pressure【Zone 3 hepatocytes are preferentially affected by steatosis due to their inherent low-oxygen microenvironment](https://pmc.ncbi.nlm.nih.gov/articles/PMC9790419/)】 and where mitochondrial dysfunction limits fatty acid oxidation【Senescent hepatocytes display mitochondrial dysfunction and reduced capacity for fatty acid metabolism](https://doi.org/10.1038/ncomms15691)】. Eliminating senescent cells with senolytics reduces fat accumulation, showing a causal link【Cellula

Hypothesis

Chronic low‑grade mitochondrial ROS triggers a retrograde signal via oxidized mtDNA that activates the cytosolic cGAS‑STING pathway. This pathway induces type‑I interferon signaling in parenchymal cells and CD38 upregulation in macrophages, which together suppress NAMPT‑mediated NAD+ biosynthesis and increase NAD+ consumption. The resulting NAD+ decline is not a passive marker of damage but an active, evolution‑conserved program that reduces energy‑intensive repair and transcriptional fidelity pathways (PARP, sirtuins) to limit the amplification of senescent‑associated secretory phenotype (SASP) and thereby protect tissue integrity in the short term.

Mechanistic Rationale

1. Mitochondrial ROS → mtDNA release – Persistent ROS oxidizes cardiolipin, promoting mitochondrial outer‑membrane permeabilization and release of oxidised mtDNA fragments into the cytosol.
2. cGAS‑STING activation – Cytosolic mtDNA binds cGAS, generating 2'3'-cGAMP that activates STING, leading to TBK1‑IRF3 phosphorylation and IFN‑β transcription.
3. IFN‑β signaling – Autocrine/paracrine IFN‑β engages JAK‑STAT1 signaling, which transcriptionally represses NAMPT (the rate‑limiting NAD+ salvage enzyme) and induces CD38 expression in tissue‑resident macrophages.
4. NAD+ pool contraction – Reduced NAMPT limits NAD+ regeneration while elevated CD38 increases NAD+ hydrolysis, driving NAD+ down.
5. Functional outcome – Lower NAD+ diminishes PARP‑mediated DNA repair (conserving NAD+ for glycolysis) and attenuates SIRT1‑dependent deacetylation of NF‑κB and PGC‑1α, shifting cell

Hypothesis

Telomere shortening does not merely count divisions; it reflects a rise in genomic informational entropy that leaks into the plasma as altered cell‑free DNA (cfDNA) fragment size heterogeneity, especially at subtelomeric repeats. We propose that the Shannon entropy of cfDNA fragment length distribution (cfDNA‑FE) serves as a quantitative proxy for telomere‑associated entropy and predicts biological age independently of methylation clocks.

Mechanistic Rationale

1. Shelterin loss → chromatin relaxation – Critically short telomeres weaken shelterin binding, permitting ATM‑dependent histone acetylation and loss of heterochromatin at subtelomeric L1HS/AluY repeats (fragment size nucleosome redistribution). This relaxed state makes nucleosomal DNA more accessible to apoptotic nucleases (CAD/DFF40), generating a broader spectrum of fragment lengths.
2. Entropy‑driven fragmentation – As telomeric repeat redundancy declines, the probability of stochastic nuclease cuts increases, raising the variance of fragment sizes. Information theory predicts that the Shannon entropy H = - Σ p_i log₂ p_i of the fragment length distribution will rise with telomere shortening (informational entropy telomere).
3. Neutrophil and colon epithelial bias – Because neutrophils and colon epithelium are the main cfDNA sources in aging (cfDNA methylation patterns), measuring cfDNA‑FE in these cell‑type‑specific fragmen

Hypothesis

Chronic activation of AMPK in senescent cells shifts the acetyl-CoA source from ACLY‑derived to ACSS2‑derived nuclear pools, thereby suppressing the SASP while enhancing lysosomal biogenesis and autophagy. This metabolic switch rewires the chromatin landscape from H3K27ac‑rich inflammatory promoters to H3K9ac‑rich repair genes, turning senescent cells into active agents of tissue homeostasis rather than passive sources of inflammation.

Mechanistic Rationale

• Senescent cells exhibit high mitochondrial citrate export via SLC25A1, feeding ACLY to produce nuclear acetyl-CoA that acetylates H3K27 at SASP loci [[https://pmc.ncbi.nlm.nih.gov/articles/PMC11643321/]].
• Concurrently, AMPK phosphorylates ACSS2 at S659, promoting its nuclear translocation under glucose stress, where it generates acetyl-CoA from acetate liberated by histone deacetylation [[https://pmc.ncbi.nlm.nih.gov/articles/PMC5521213/]][[https://pubmed.ncbi.nlm.nih.gov/28552616/]].
• We propose that AMPK activation creates a competitive advantage for ACSS2 over ACLY by (1) lowering cytosolic acetyl-CoA through increased ACLY inhibition via phosphorylation, and (2) raising nuclear acetate availability via heightened HDAC activity on SASP chromatin, which ACSS2 then recycles.
• The resulting acetyl-CoA fuels H3K9ac at TFEB‑bound lysosomal/autophagy promoters, reinforcing a clearance program that further degrades SASP mRNA and protein, establishing a negative feedback loop.

Predictions and Experimental Design

1. **Pharmacological AMPK activation (e.g., AICAR or metformin) in senescent human fibr

The hypothesis posits that somatic mtDNA mutations activate the integrated stress response (ISR) transcription factor ATF4, which then remodels chromatin at enhancers of GLI‑target genes, leading to aberrant Hedgehog pathway activation in aged stromal fibroblasts. This reactivation drives a maladaptive repair program characterized by excessive extracellular matrix deposition and impaired stem‑cell niche function, contributing to age‑related tissue fibrosis.

Key mechanistic steps:

1. mtDNA point mutations increase mitochondrial unfolded protein response (UPRmt) and ISR signaling, elevating ATF4 protein levels (as shown in POLG mutator mice) [https://www.aging-us.com/article/100109/text].
2. ATF4 binds to specific DNA motifs upstream of GLI1 and GLI2 promoters, recruiting histone acetyltransferases (e.g., p300) that increase H3K27ac marks, thereby opening chromatin at these loci.
3. Open chromatin permits GLI transcription factors to access their target enhancers even in the absence of canonical Hedgehog ligand, resulting in ligand‑independent GLI activation.
4. Persistent GLI signaling upregulates profibrotic genes (COL1A1, ACTA2) and suppresses adipogenic differentiation, shifting fibroblast phenotype toward a myofibroblast‑like state.
5. Secreted mitokines such as GDF15 amplify this effect systemically, propagating the fibrotic response to distant tissues [https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2025.1652353/full].

Testable predictions: - Fibroblasts isolated from POLG mutator mice will show higher basal GLI1/GLI2 tr

Hypothesis

Nuclear acetyl-CoA levels in senescent cells act as a rheostat that shifts the senescence-associated secretory phenotype (SASP) from a tumor‑suppressive, growth‑arresting state to a pro‑inflammatory, tissue‑damaging state by differentially acetylating histones at NF‑κB versus FOXO3 target promoters.

Mechanistic Rationale

Senocytes integrate metabolic cues into epigenetic decisions via acetyl-CoA–dependent histone acetylation. When nuclear acetyl-CoA is abundant, ACSS2–generated acetyl groups preferentially acetylate H3K27 at promoters of NF‑κB‑driven SASP components (IL-6, IL-8, CCL2), enhancing their transcription and creating a feed‑forward inflammatory loop. Conversely, limited nuclear acetyl-CoA reduces acetylation at these sites while permitting basal acetylation of FOXO3‑controlled promoters (e.g., IGFBP7, p21) that enforce cell-cycle arrest and secrete factors with tumor-suppressive and wound-healing properties. This bias explains the observed context-dependence of SASP: tissues with high acetate uptake or ACSS2 activity (e.g., inflamed macrophages) favor a detrimental SASP, whereas low-acetyl-CoA niches preserve a protective secretome.

Testable Predictions

1. Pharmacological elevation of nuclear acetyl-CoA (via acetate supplementation or ACSS2 over-expression) in senescent fibroblasts will increase NF-κB-p65 binding and H3K27ac at IL6 and IL8 promoters, while decreasing FOXO3 occupancy at IGFBP7.
2. CRISPR-mediated knock-down of ACSS2 in senescent cells will shift SASP composition toward higher IGFBP7 and lower IL-6, independent of p16^INK4a^ l

Hypothesis

Age‑related gut dysbiosis accelerates presbyphonia by reducing circulating short‑chain fatty acids (SCFAs) and increasing lipopolysaccharide (LPS) translocation, which directly activates TLR4 on vocal fold lamina propria fibroblasts, upregulating matrix metalloproteinases (MMPs) and degrading hyaluronan‑rich extracellular matrix. This peripheral mechanism operates independently of central vagal signaling, implying that microbiome‑targeted interventions can rescue vocal fold biomechanics even when neural pathways are compromised.

Mechanistic Rationale

• SCFA loss diminishes fibroblast homeostasis: Butyrate and propionate inhibit HDAC activity in fibroblasts, promoting expression of tissue‑inhibitor of metalloproteinases (TIMPs) and suppressing NF‑κB‑driven MMP transcription. Age‑associated dysbiosis lowers fecal butyrate by ~40 % (see [PMC10798364]), removing this brake on MMP synthesis.
• LPS‑TLR4 signaling amplifies proteolytic tone: Translocated LPS binds TLR4 on lamina propria fibroblasts, triggering MyD88‑dependent NF‑κB activation and upregulating MMP‑1, MMP‑3, and MMP‑9. Concurrently, LPS reduces fibroblast production of hyaluronan synthase 2, thinning the extracellular matrix ground substance.
• Vagal anti‑inflammatory pathway is secondary: While the vagus nerve can modulate inflammation via acetylcholine‑α7nAChR signaling, denervation studies show that SCFA supplementation still restores fibroblast TIMP/MMP balance, indicating a direct metabolite effect that does not require intact vagal tone.
• Feed‑forward loop: MMP‑generated ma

Hypothesis

Acarbose extends lifespan not only through metabolic improvement but also by eliciting low‑level gastrointestinal nociceptive signaling that acts as a hormetic stressor. The undigested starch that reaches the colon is fermented by microbiota, producing short‑chain fatty acids (SCFAs) and gaseous metabolites that cause luminal distension. This distension activates mechanosensitive and chemosensitive nociceptors (chiefly TRPV1 and Piezo2) on intestinal afferents, generating a mild, chronic pain signal. In males, androgen‑dependent up‑regulation of TRPV1 amplifies this signal, which then engages central stress‑response pathways (HSF1‑mediated heat‑shock response, Nrf2‑driven antioxidant gene expression, and enhanced autophagy) that improve proteostasis and delay aging. Consequently, suppressing this nociceptive input should blunt acarbose’s longevity effect without altering its metabolic or microbiome actions.

Testable Predictions

1. Pharmacological blockade of visceral nociception will reduce acarbose‑mediated lifespan extension. Male mice receiving acarbose plus a selective TRPV1 antagonist (e.g., capsazepine) or a Piezo2‑blocking peptide will show a significantly shorter survival than acarbose‑only controls, whereas female mice will exhibit a smaller or non‑significant change.
2. Nociceptive activation markers will rise with acarbose treatment. Acarbose‑fed mice will exhibit increased spinal cord phosphorylation of TRPV1 downstream effectors (p‑ERK, p‑CREB) and elevated colonic c‑Fos immunoreactivity compared with pair‑fed controls; these increas